
Last updated: 2026-10-13 13:46:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Advanced Biomed Inc. (ADVB) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $5.28, with a market capitalisation of $8.77M and a P/E ratio of 1.65. Over the past 52 weeks, its price has ranged from $3.61 to $24.23. This page covers its latest market performance, valuation, price trends and company information.
$8.77M | |
$5.28 | |
$82.00 | |
$3.61 | |
$5.28 | |
386.00 | |
1.77M | |
1.65 | |
$24.23 | |
$3.61 | |
-- | |
-- |
Advanced Biomed Inc. (ADVB) is currently trading at $5.28 as of 2026-10-13 13:42:00, up 0.09% ($0.00) from the previous close of $5.28
During today's regular trading session, ADVB has traded between $3.61 and $82.00, with a trading volume of 386.00 shares. The current price is near the lower end of today's range.
Over the past seven days, Advanced Biomed Inc. (ADVB) moved from $6.73 to $5.28, representing a decline of 21.55% ($1.45).
The stock traded between $5.18 and $7.05 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 18.96 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 8.1%
ADVB is currently trading at $5.28, placing it 8.1% of the way from its 52-week low of $3.61 to its 52-week high of $24.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 31 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Advanced Biomed Inc. (ADVB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.